Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-28T20:04:40.910Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of Varicella-Zoster Virus (VZV) Fluorescent- Antibody-to-Membrane-Antigen (FAMA) Testing on Sensitivity of Determining VZV Immunity in Healthcare Workers and on Furlough Days

Published online by Cambridge University Press:  02 January 2015

Lori Rolando ,
William J. Schneider ,
Sharon Steinberg ,
Sulin Low ,
Jeffrey Stiles ,
Luz Gomez ,
Anne A. Gershon  and
Arthur E. Brown
Lori Rolando
Affiliation:
Department of Community and Preventive Medicine, Mt Sinai School of Medicine, New York, New York
William J. Schneider
Affiliation:
Employee Health and Wellness Services, New York, New York Infectious Disease Service, New York, New York
Sharon Steinberg
Affiliation:
Memorial Sloan Kettering Cancer Center, the Infectious Disease Division, Department of Pediatrics, Columbia University Medical Center, New York, New York
Sulin Low
Affiliation:
Employee Health and Wellness Services, New York, New York
Jeffrey Stiles
Affiliation:
Clinical Microbiology Laboratory, New York, New York
Luz Gomez
Affiliation:
Employee Health and Wellness Services, New York, New York
Anne A. Gershon
Affiliation:
Memorial Sloan Kettering Cancer Center, the Infectious Disease Division, Department of Pediatrics, Columbia University Medical Center, New York, New York
Arthur E. Brown*
Affiliation:
Employee Health and Wellness Services, New York, New York Infectious Disease Service, New York, New York
*
Employee Health and Wellness Services, Memorial Sloan Kettering Cancer Center, 222 East 70th Street, New York, NY 10021 (brown2@mskcc.org)
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 9 , September 2010 , pp. 972 - 974
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Division of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University, Nashville, Tennessee

References

1. Marin, M, Güris, D, Chaves, SS, Schmid, S, Seward, JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007:56(RR-4):1–40.Google ScholarPubMed
2. Atkinson, W, Wolfe, S, Hamborsky, J, Mclntyre, L, eds. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundation, 2009.Google Scholar
3. Weber, D, Rutala, W, Parham, C. Impact and costs of varicella prevention in a university hospital. Am J Public Health 1988;78:19–23.Google Scholar
4. Almuneef, M, Memish, Z, Abbas, M, Balkhy, H. Screening healthcare workers for varicella-zoster virus: can we trust the history? Infect Control Hosp Epidemiol 2004;25:595–598.CrossRefGoogle ScholarPubMed
5. Gallagher, J, Quaid, B, Cryan, B. Susceptibility to varicella-zoster virus infection in healthcare workers. Occup Med (Lond) 1996;46:289–292.Google Scholar
6. Williams, V, Gershon, A, Brunell, P. Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence.. J Infect Dis 1974;130:669–672.Google Scholar
7. LaRussa, P, Steinberg, S, Waithe, E, Hanna, B, Holzman, R. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test. J Clin Microbiol 1987;25:2059–2062.Google Scholar
8. Sauerbrei, A, Wutzler, P. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol 2006;44:3094–3097.Google Scholar
9. Landry, M, Cohen, S, Mayo, D, Fong, C, Andiman, W. Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus. J Clin Miaobiol 1987;25:832–835.CrossRefGoogle Scholar
10. Breuer, J, Schmid, S, Gershon, A. Use and limitations of varicella-zoster virus-specific serologic testing to evaluate breakthrough disease in vaccines and to screen for susceptibility to varicella. J Infect Dis 2008;197: S147–S151.CrossRefGoogle ScholarPubMed